Search Results for 'Aker BioMarine ASA'
Refine by Dates:
Refine By
Content Type
BlogBreaking News
Buyers Guide Companies
Classifieds
Columns
Consumer Trends
Editorials
Features
Health E-Insights
Industry Events
Industry News
Market Research
Monograph Center
Naturally Filtered
Online Exclusives
Patents
Peer-reviewed Research
People In The News
Products
Recent Certifications & Approvals
Suppliers Corner
Supplier Research
Supply Source
TrendSense
Webinars
Article Results
By Sean Moloughney
Published October 1, 2011
As an integrated biotechnology company that supplies biomarine ingredients through an optimized value chain, Oslo, Norway-based Aker BioMarine ASA is uniquely positioned to deliver value-added solutions to the nutraceutical and aquaculture markets. Read More »
By Rebecca Wright, Editor
Published April 1, 2011
Growth has been flat for more than a decade—a sign of maturity or a new beginning? Maybe both. Read More »
Published November 2, 2010
Trygg Pharma, Inc., a subsidiary of Aker BioMarine, Oslo, Norway, is currently enrolling patients in its clinical trial, a Phase III clinical study assessing the efficacy of AKR 963—an investigational candidate drug developed by the company&mda… Read More »
Published October 20, 2010
A clinical study in children with attention deficit hyperactive disorder (ADHD) suggests that Superba krill oil from Aker BioMarine offered significant improvements in both clinical scores and in identified EEG patterns as compared to typical ADHD EE… Read More »
Published October 6, 2010
A new study published in the journal Lipids provides detailed characterization of the phospholipid fatty acids profile for Superba krill oil, from Aker BioMarine.
Superba krill oil provides the majority of its omega… Read More »
Published October 1, 2010
Trygg Pharma AS, a company jointly owned by Norwegian biotechnology company Aker BioMarine ASA and New York-based investment fund Lindsay Goldberg, has acquired omega 3 supplier EPAX AS from Austevoll Seafood ASA. As part of the agreement, EPAX has e… Read More »
Published September 20, 2010
A new study indicates Superba krill oil, from Aker BioMarine decreased rheumatoid arthritis scores in an experimental animal model. Results were published in BMC Musculoskeletal Disorders.
Conducted by researchers at MD Bioscie… Read More »
Published September 10, 2010
Aker BioMarine, Oslo, Norway, has named Eric Anderson vice president, Sales & Marketing while also appointing Todd Norton vice president, New Business Development. They will be responsible for educating the natural products industry and consumers… Read More »
Published September 3, 2010
Trygg Pharma AS, a company jointly owned by Norwegian biotechnology company Aker BioMarine ASA and New York-based investment fund Lindsay Goldberg, has acquired omega 3 supplier EPAX AS from Austevoll Seafood ASA. Read More »
Published May 12, 2010
Norway-based Aker BioMarine and Lipogen, Israel, have joined forces to develop an innovative phospholipids formula for cognitive health. The target formula is a unique matrix of Lipogen PS phosphatidylserine (PS) produced from Aker BioMarine’s… Read More »
Published March 1, 2010
Aker BioMarine, Oslo, Norway, has obtained Novel Food approval in the EU for its Superba krill oil from the Finnish Food Safety Authority. Consequently, Superba krill oil can be sold in all countries within the EU.… Read More »
